Interactions between dopamine neurons and myelin-producing cells in the brain.
Axo-glial interactions between midbrain dopamine neuron axons and oligodendrocyte lineage cells in the corpus callosum.
This study is looking at how certain brain cells that produce myelin interact with dopamine neurons, which could help us understand and find new treatments for conditions like schizophrenia and Parkinson's disease that affect brain function.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | College of Staten Island NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10673849 on NIH RePORTER |
What this research studies
This research investigates how dopamine neurons in the midbrain interact with oligodendrocyte precursor cells (OPCs) in the corpus callosum, which are crucial for producing myelin in the brain. The study aims to understand how these interactions affect myelin regulation, which is important for brain function and may influence neuropsychiatric disorders. By examining these cellular interactions, the research seeks to uncover potential therapeutic targets for conditions like schizophrenia and Parkinson's disease, where myelin regulation is disrupted.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults experiencing neuropsychiatric disorders such as schizophrenia, addiction, or Parkinson's disease.
Not a fit: Patients without neuropsychiatric disorders or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for neuropsychiatric disorders by improving myelin repair and function in the brain.
How similar studies have performed: Previous research has shown promising results in understanding myelin regulation and its implications for neuropsychiatric disorders, suggesting that this approach may lead to significant advancements.
Where this research is happening
New York, United States
- College of Staten Island — New York, United States (Active)
Researchers
- Principal investigator: Yetnikoff, Leora — College of Staten Island
- Study coordinator: Yetnikoff, Leora
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.